Quidel Overview

  • Founded
  • 1979
Founded
  • Status
  • Public
  • Employees
  • 1,370
Employees
  • Stock Symbol
  • QDEL
Stock Symbol
  • Investments
  • 9
  • Share Price
  • $157.32
  • (As of Tuesday Closing)

Quidel General Information

Description

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.

Contact Information

Website
www.quidel.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Stock Exchange
NAS
Primary Office
  • 9975 Summers Ridge Road
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quidel Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$157.32 $152.73 $103.31 - $288.70 $6.55B 41.6M 717K $21.40

Quidel Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 4,616,750 7,596,401 3,203,502 2,018,817
Revenue 1,837,209 1,661,668 534,890 522,285
EBITDA 1,214,189 1,099,031 139,795 133,933
Net Income 899,555 810,287 72,921 74,183
Total Assets 1,807,652 1,871,164 910,867 806,371
Total Debt 144,612 108,505 112,300 107,567
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Quidel Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Quidel‘s full profile, request access.

Request a free trial

Quidel Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is sep
Diagnostic Equipment
San Diego, CA
1,370 As of 2020
00000000

00000000

ed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nost
0000000000 000000000
Mechelen, Belgium
000 As of 0000
00000
000000000 00000

00000000

it in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000 000000000
Puteaux, France
000 As of 0000
000.00
0000 0000-00-00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quidel Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocartis Formerly VC-backed Mechelen, Belgium 000 00000 000000000 00000
000000000000 Private Equity-Backed Puteaux, France 000 000.00 000000000000
0000000 Corporate Backed or Acquired Québec, Canada 000 000000&0
00000000000 Corporation Waltham, MA 00000 00000000
000000000 Venture Capital-Backed Dublin, Ireland 00 000.00 0000000000 0 000.00
You’re viewing 5 of 25 competitors. Get the full list »

Quidel Executive Team (13)

Name Title Board Seat Contact Info
Douglas Bryant Chief Executive Officer & Board Member
Randall Steward Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Robert Bujarski Chief Operating Officer, Operations
Paul Lawrence Ph.D Chief Technology Officer
Ruben Argueta Director, Investor Relations
You’re viewing 5 of 13 executive team members. Get the full list »

Quidel Board Members (13)

Name Representing Role Since
000 000000 Self Board Member 000 0000
0000000 000000 Quidel Board Member 000 0000
0000000 000000 Quidel Chief Executive Officer & Board Member 000 0000
000000 0000000 00 Self Board Member 000 0000
0000 0000000 Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Quidel Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quidel Investments & Acquisitions (9)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 (000000 000 06-Oct-2017 000000000000000000 00000 Other Devices and Supplies 0000000 000000
00000 (00000000 00 06-Oct-2017 000000000 00000 00 Buildings and Property 0000000 000000
000000 00000000000 28-Sep-2017 000000000000000000 Other Devices and Supplies
000 00000000000 (0 16-May-2017 000000000 00000 00 0000 Buildings and Property 0000000 000000
AnDiaTec 23-Oct-2013 Merger/Acquisition 00.00 Diagnostic Equipment 0000000 000000
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Quidel Subsidiaries (2)

Company Name Industry Location Founded
BioHelix Biotechnology Beverly, MA 2004
00000000 Diagnostic Equipment Kornwestheim, Germany 0000
To view Quidel’s complete subsidiaries history, request access »

Quidel Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 12-Apr-2002 00000 00000 00 00.000 Completed
  • 5 buyers
To view Quidel’s complete exits history, request access »